Epidemiology of Hepatitis C Virus (HCV) Infection

Overview

Journal Int J Med Sci

Specialty General Medicine

Date 2006 Apr 15

PMID 16614741

Citations 114

Authors

Theodore Sy

M Mazen Jamal

Affiliations

Soon will be listed here.

Abstract

Hepatitis C virus remains a large health care burden to the world. Incidence rates across the world fluctuate and are difficult to calculate given the asymptomatic, often latent nature of the disease prior to clinical presentation. Prevalence rates across the world have changed as well with more countries aware of transfusion-related hepatitis C and more and more evidence supporting intravenous drug use as the leading risk factor of spread of the virus. This article reviews current hepatitis C virus prevalence and genotype data and examines the different risk factors associated with the virus.

Citing Articles

Effect of Hepatitis C Infection on Semen Parameters of Men From Rawalpindi and Islamabad, Punjab, Pakistan.

Uddin J, Akhter S, Asad M, Irfan M, Qayyum M, Aijaz M Am J Mens Health. 2025; 19(1):15579883251316564.

PMID: 39981641 PMC: 11843681. DOI: 10.1177/15579883251316564.

The hidden epidemic of occult hepatitis B and C among injection drug users (IDUs): A call for action.

Elkashef K, Abdel Fattah N, Mesbah N, El-Shaarawy F, Amer M, Fakhr A Int J Health Sci (Qassim). 2025; 19(1):22-30.

PMID: 39760055 PMC: 11699232.

Elimination of HCV Infection: Recent Epidemiological Findings, Barriers, and Strategies for the Coming Years.

Torre P, Festa M, Sarcina T, Masarone M, Persico M Viruses. 2024; 16(11).

PMID: 39599906 PMC: 11598908. DOI: 10.3390/v16111792.

Prevalence of Occult Hepatitis C Virus Infection in Egyptian Patients with Lymphoma: A New Vision.

Elkashef K, Emam W, Mesbah N, Abo-Elmatty D, Abdel-Hamed A Diagnostics (Basel). 2022; 12(4).

PMID: 35454063 PMC: 9029505. DOI: 10.3390/diagnostics12041015.

Prevalence of transfusion-transmitted infections in multiple blood transfusion-dependent thalassemic patients in Asia: A systemic review.

Riaz M, Abbas M, Rasool G, Baig I, Mahmood Z, Munir N Int J Immunopathol Pharmacol. 2022; 36:3946320221096909.

PMID: 35452334 PMC: 9036341. DOI: 10.1177/03946320221096909.

References

Perez C, Suarez E, Torres E, Roman K, Colon V . Seroprevalence of hepatitis C virus and associated risk behaviours: a population-based study in San Juan, Puerto Rico. Int J Epidemiol. 2005; 34(3):593-9. DOI: 10.1093/ije/dyi059. View

Backmund M, Reimer J, Meyer K, Gerlach J, Zachoval R . Hepatitis C virus infection and injection drug users: prevention, risk factors, and treatment. Clin Infect Dis. 2005; 40 Suppl 5:S330-5. DOI: 10.1086/427475. View

Shah H, Jafri W, Malik I, Prescott L, Simmonds P . Hepatitis C virus (HCV) genotypes and chronic liver disease in Pakistan. J Gastroenterol Hepatol. 1998; 12(11):758-61. DOI: 10.1111/j.1440-1746.1997.tb00366.x. View

Sulkowski M, Thomas D . Hepatitis C in the HIV-Infected Person. Ann Intern Med. 2003; 138(3):197-207. DOI: 10.7326/0003-4819-138-3-200302040-00012. View

Zusinaite E, Metskula K, Salupere R . Autoantibodies and hepatitis C virus genotypes in chronic hepatitis C patients in Estonia. World J Gastroenterol. 2005; 11(4):488-91. PMC: 4250796. DOI: 10.3748/wjg.v11.i4.488. View

Frommel D, Berhe N, Aussel L, Verdier M, Preux P, Denis F . A survey of antibodies to hepatitis C virus in Ethiopia. Am J Trop Med Hyg. 1993; 49(4):435-9. DOI: 10.4269/ajtmh.1993.49.435. View

Osoba A . Hepatitis C virus genotypes in Saudi Arabia. Saudi Med J. 2002; 23(1):7-12. View

Bassily S, Hyams K, Fouad R, Samaan M, HIBBS R . A high risk of hepatitis C infection among Egyptian blood donors: the role of parenteral drug abuse. Am J Trop Med Hyg. 1995; 52(6):503-5. DOI: 10.4269/ajtmh.1995.52.503. View

Akhtar S, Younus M, Adil S, Jafri S, Hassan F . Hepatitis C virus infection in asymptomatic male volunteer blood donors in Karachi, Pakistan. J Viral Hepat. 2004; 11(6):527-35. DOI: 10.1111/j.1365-2893.2004.00518.x. View

10.

Conlon P, Walshe J, Smyth E, McNamara E, Donohoe J, Carmody M . Lower prevalence of anti-hepatitis C antibody in dialysis and renal transplant patients in Ireland. Ir J Med Sci. 1993; 162(4):145-7. DOI: 10.1007/BF02942105. View

11.

Alter M, Nainan O, McQuillan G, Gao F, Moyer L, Kaslow R . The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med. 1999; 341(8):556-62. DOI: 10.1056/NEJM199908193410802. View

12.

Panigrahi A, Panda S, Dixit R, Rao K, Acharya S, Dasarathy S . Magnitude of hepatitis C virus infection in India: prevalence in healthy blood donors, acute and chronic liver diseases. J Med Virol. 1997; 51(3):167-74. View

13.

Hayashi J, Yoshimura E, Nabeshima A, Kishihara Y, Ikematsu H, Hirata M . Seroepidemiology of hepatitis C virus infection in hemodialysis patients and the general population in Fukuoka and Okinawa, Japan. J Gastroenterol. 1994; 29(3):276-81. DOI: 10.1007/BF02358365. View

14.

Kuperan P, Choon A, Ding S, Lee G . Prevalence of antibodies to hepatitis C virus in relation to surrogate markers in a blood donor population of Singapore. Southeast Asian J Trop Med Public Health. 1993; 24 Suppl 1:127-9. View

15.

Mathei C, Robaeys G, Van Damme P, Buntinx F, Verrando R . Prevalence of hepatitis C in drug users in Flanders: determinants and geographic differences. Epidemiol Infect. 2005; 133(1):127-36. PMC: 2870231. DOI: 10.1017/s0950268804002973. View

16.

Ilako F, McLigeyo S, Riyat M, Lule G, Okoth F, Kaptich D . The prevalence of hepatitis C virus antibodies in renal patients, blood donors and patients with chronic liver disease in Kenya. East Afr Med J. 1995; 72(6):362-4. View

17.

el Guneid A, Gunaid A, ONeill A, Zureikat N, Coleman J, Murray-Lyon I . Prevalence of hepatitis B, C, and D virus markers in Yemeni patients with chronic liver disease. J Med Virol. 1993; 40(4):330-3. DOI: 10.1002/jmv.1890400413. View

18.

Nordenfelt E, Lofgren B, Widell A, Hansson B, Zhang Y, HAGSTAM K . Hepatitis C virus infection in hemodialysis patients in southern Sweden: epidemiological, clinical, and diagnostic aspects. J Med Virol. 1993; 40(4):266-70. DOI: 10.1002/jmv.1890400403. View

19.

Zhang Y, Hansson B, Widell A, Nordenfelt E . Hepatitis C virus antibodies and hepatitis C virus RNA in Chinese blood donors determined by ELISA, recombinant immunoblot assay and polymerase chain reaction. APMIS. 1992; 100(9):851-5. DOI: 10.1111/j.1699-0463.1992.tb04010.x. View

20.

Amin J, Gidding H, Gilbert G, Backhouse J, Kaldor J, Dore G . Hepatitis C prevalence--a nationwide serosurvey. Commun Dis Intell Q Rep. 2005; 28(4):517-21. View